Merck KGaA (MKKGY)
31.09
+0.02
(+0.06%)
USD |
OTCM |
Apr 19, 15:59
Merck Cash from Investing (TTM): -2.048B for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -2.048B |
September 30, 2023 | -1.946B |
June 30, 2023 | -2.085B |
March 31, 2023 | -2.993B |
December 31, 2022 | -2.893B |
September 30, 2022 | -2.937B |
June 30, 2022 | -3.157B |
March 31, 2022 | -2.672B |
December 31, 2021 | -1.867B |
September 30, 2021 | -1.523B |
June 30, 2021 | -1.683B |
March 31, 2021 | -1.629B |
December 31, 2020 | -1.530B |
September 30, 2020 | -6.775B |
June 30, 2020 | -6.096B |
March 31, 2020 | -6.832B |
December 31, 2019 | -6.888B |
September 30, 2019 | 1.755B |
June 30, 2019 | 1.732B |
March 31, 2019 | 2.475B |
December 31, 2018 | 2.587B |
September 30, 2018 | -1.099B |
June 30, 2018 | -1.016B |
March 31, 2018 | -1.132B |
December 31, 2017 | -1.299B |
Date | Value |
---|---|
September 30, 2017 | -1.431B |
June 30, 2017 | -1.523B |
March 31, 2017 | -1.298B |
December 31, 2016 | -556.70M |
September 30, 2016 | -16.27B |
June 30, 2016 | -15.54B |
March 31, 2016 | -13.37B |
December 31, 2015 | -13.25B |
September 30, 2015 | 1.444B |
June 30, 2015 | 489.32M |
March 31, 2015 | -3.247B |
December 31, 2014 | -2.183B |
September 30, 2014 | -1.010B |
June 30, 2014 | -571.42M |
March 31, 2014 | 773.31M |
December 31, 2013 | -1.161B |
September 30, 2013 | -1.569B |
June 30, 2013 | -2.021B |
March 31, 2013 | -2.334B |
December 31, 2012 | -1.489B |
September 30, 2012 | -921.87M |
June 30, 2012 | -1.577B |
March 31, 2012 | -975.05M |
December 31, 2011 | -1.249B |
September 30, 2011 | -1.369B |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-6.888B
Minimum
Dec 2019
1.755B
Maximum
Sep 2019
-2.740B
Average
-2.085B
Median
Jun 2023
Cash from Investing (TTM) Benchmarks
Affimed NV | -39.04M |
InflaRx NV | -19.16M |
MorphoSys AG | -- |
BioNTech SE | -7.529B |
Immatics NV | -33.98M |